Back to search
FDAFDA · Food and drugs·Recall number Z-2684-2017

Proteus 235, Proton Therapy System Product Usage: The Proton Therapy System - Proteus 235 is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

Published July 12, 2017 · Recall initiated: December 13, 2016

Summary

FDA records medical device Class II recall Z-2684-2017, published July 12, 2017 and initiated December 13, 2016. Recalling firm: Ion Beam Applications S.A.; Status: Terminated; Reported quantity: 6 worldwide and 5 in the U.S.; Lot: Serial Numbers: PAT.006, PAT.108, PAT.112, PAT.113, SAT.116, PAT.003. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Software issue

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ion Beam Applications S.A.
Distributor
Distributed to FL, VA, IL, NJ, WA and South Korea
Lot
Serial Numbers: PAT.006, PAT.108, PAT.112, PAT.113, SAT.116, PAT.003
Risk classification
Class II
Area (FDA)
device
Country
Belgium

Related recalls

Questions about this recall

Was Proteus 235, Proton Therapy System Product Usage: The Proton Therapy System - Proteus 235 is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck. recalled?

Yes. FDA published recall Z-2684-2017 on July 12, 2017. Reported hazard: Software issue

What should I do if I have this product?

Voluntary: Firm initiated · Letter